SINOVAC BIOTECH LTD (SVA)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$386.0M$361.4M$470.2M$1.47B$19.37B$510.6M$246.1M$229.7M$174.3M$72.4M$56.8M$33.4M$84.2M
Gross profit$262.0M$220.7M$323.3M$815.2M$18.38B$443.4M$213.6M$204.9M$154.1M$50.0M$49.0M$47.5M$51.3M$30.1M$35.7M$16.7M$64.1M
Research & development$216.2M$270.7M$350.2M$478.7M$152.7M$48.8M$24.3M$21.9M$20.5M$12.6M$9.5M$10.9M$8.1M$17.0M$9.0M$8.5M$4.4M
Operating expenses$752.1M$726.2M$1.04B$1.32B$758.1M$227.8M$145.0M$159.6M$108.7M$49.5M$45.3M$45.6M$41.3M$51.3M$32.3M$30.0M$22.0M
Operating income−$490.1M−$505.5M−$714.0M−$509.0M$17.62B$215.6M$68.6M$45.3M$45.4M$504,000$3.7M$1.9M$9.9M−$21.2M$3.4M−$13.4M$42.1M
EBITDAderived−$391.4M−$394.3M−$555.5M−$355.8M$17.70B$219.4M$73.1M$50.2M−$16.7M$8.2M−$9.1M$44.4M
Net income−$198.8M$40.7M−$13.5M$14.5M$8.12B$110.4M$44.9M$21.8M$25.8M−$596,000−$1.4M−$1.5M$7.4M−$18.7M−$844,696−$8.5M$20.0M
Basic EPSper diluted share-$0.83$1.27-$0.19$0.20$113.54$1.06$0.42$0.34$0.45-$0.01-$0.03-$0.03$0.13-$0.27-$0.02-$0.16$0.47
Diluted EPSper diluted share-$0.83$1.27-$0.19$0.20$113.44$0.97$0.41$0.34$0.45-$0.01-$0.03-$0.03$0.13-$0.27-$0.02-$0.16$0.46

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.